5-Bromo-1-methylpyrimidine-2,4(1H,3H)-dione
95%
- Product Code: 173201
CAS:
6327-97-5
Molecular Weight: | 205.01 g./mol | Molecular Formula: | C₅H₅BrN₂O₂ |
---|---|---|---|
EC Number: | MDL Number: | MFCD00038053 | |
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | Room temperature, dry |
Product Description:
Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of antiviral and anticancer agents. Its structure supports modification for nucleoside analogs, which can interfere with viral replication or DNA synthesis in cancer cells. Also employed in agrochemical research for designing bioactive molecules. Commonly utilized in medicinal chemistry for structure-activity relationship (SAR) studies due to its halogenated pyrimidine core, enabling further functionalization through cross-coupling reactions.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
250mg | 10-20 days | ฿7,990.00 |
+
-
|
1g | 10-20 days | ฿18,810.00 |
+
-
|
5-Bromo-1-methylpyrimidine-2,4(1H,3H)-dione
Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of antiviral and anticancer agents. Its structure supports modification for nucleoside analogs, which can interfere with viral replication or DNA synthesis in cancer cells. Also employed in agrochemical research for designing bioactive molecules. Commonly utilized in medicinal chemistry for structure-activity relationship (SAR) studies due to its halogenated pyrimidine core, enabling further functionalization through cross-coupling reactions.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :